DIAGNOSTIC AND THERAPEUTIC CENTER OF ATHENS HYGEIA SA Resolutions of Annual General Meeting of Shareholders on 04/05/2017

DIAGNOSTIC AND THERAPEUTIC CENTER OF ATHENS HYGEIA SA

(hereinafter "the Company'), in accordance with paragraph 4.1.3.3 of the Athens Exchange Regulation, announces that the Annual General Meeting of the Company Shareholders was held on 04/05/2017 and was attended in person or by proxy holder by the shareholders representing 73.51 % of the paid-up share capital.

Item 1: Submission and approval of the Separate and Consolidated Financial Statements for the 2016 fiscal year, and the respective reports of the BoD and the Chartered Accountants/Auditors.

The General Meeting approved the Separate and Consolidated Annual Financial Statements for the fiscal year ended 31/12/2016, as well as the Report of the BoD and the Report of the Chartered Accountants/Auditors.

Total valid votes: 11 shareholders who represented 224,738,526 shares and voting rights in total, i.e. 73.51% of the Company's paid-up share capital.

For: 11 shareholders who represented 224,738,526 shares and voting rights in total,

i.e. 73.51% of the Company's paid-up share capital. Against: None of the shareholders.

Abstentions: None of the shareholders.

Item 2: Discharge of BoD Members and Chartered Accountants/Auditors from any liability with regard to the 2016 fiscal year activities.

The General Meeting approved the activities for the 2016 fiscal year and discharged the BoD Members and the Chartered Accountants/Auditors of the Company from any liability with respect to said activities.

Total valid votes: 11 shareholders who represented 224,738,526 shares and voting rights in total, i.e. 73.51% of the Company's paid-up share capital.

For: 10 shareholders who represented 224,698,526 shares and voting rights in total,

i.e. 73.50% of the Company's paid-up share capital. Against: None of the shareholders.

Abstentions: 1 shareholder who represented 40,000 shares and voting rights in total,

i.e. 0.01% of the Company's paid-up share capital.

Item 3: Appointment of Chartered Accountants/Auditors for the 2017 fiscal year.

The General Meeting awarded the mandatory audit of the financial statements for the current fiscal year to Audit Company Grant Thornton SA, with registered offices in P. Faliro, Attica, at 56 Zefyrou Street, registered in the Special Register referred to in Article 13(5) of Presidential Decree 226/1992 under Reg. No. 127, pursuant to the legislation in force.

Total valid votes: 11 shareholders who represented 224,738,526 shares and voting rights in total, i.e. 73.51% of the Company's paid-up share capital.

For: 11 shareholders who represented 224,738,526 shares and voting rights in total,

i.e. 73.51% of the Company's paid-up share capital. Against: None of the shareholders.

Abstentions: None of the shareholders.

Item 4: Approval of remunerations and contracts in accordance with Articles 23a and 24 of Codified Law 2190/1920.

The General Meeting approved the remunerations paid to Members of the BoD, in line with the provisions of Codified Law 2190/1920, Article 24(2) and the draft that had been posted on the Company website.

Total valid votes: 11 shareholders who represented 224,738,526 shares and voting rights in total, i.e. 73.51% of the Company's paid-up share capital.

For: 11 shareholders who represented 224,738,526 shares and voting rights in total,

i.e. 73.51% of the Company's paid-up share capital. Against: None of the shareholders.

Abstentions: None of the shareholders.

Item 5: Approval of replacements of BoD and Control Committee Members.

The General Meeting approved the appointment of the following new Members to the Company's BoD, replacing Members who resigned: a) Messrs Athanasios Papanikolaou, Dimitrios-Eleftherios Mantzavinos, Konstantina Psoni, Fotios Karatzenis and Nikolaos Damaskopoulos, pursuant to the relevant BoD decision on 08/12/2016, and b) Mr Athanasios Christopoulos, pursuant to the relevant BoD decision on 20/03/2017. It further approved the appointment of Messrs Athanasios Christopoulos and Nikolaos Damaskopoulos as Independent BoD Members, given that they meet the criteria set out in Law 3016/2002, Article 4.

It also approved the appointment of Mr Nikolaos Damaskopoulos, pursuant to the relevant BoD decision on 08/12/2016, and Mr Athanasios Christopoulos, pursuant to the relevant BoD decision on 20/03/2017, to the Control Committee as new members, replacing the members who resigned.

Total valid votes: 11 shareholders who represented 224,738,526 shares and voting rights in total, i.e. 73.51% of the Company's paid-up share capital.

For: 11 shareholders who represented 224,738,526 shares and voting rights in total,

i.e. 73.51% of the Company's paid-up share capital. Against: None of the shareholders.

Abstentions: None of the shareholders.

Item 6: Other issues/announcements.

There were no other issues for discussion or announcements.

Hygeia SA Diagnostic & Therapeutic Center of Athens published this content on 08 May 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 08 May 2017 11:02:02 UTC.

Original documenthttp://www.hygeia.gr/en/media/files/1419-ΑΠΟΦΑΣΕΙΣ ΤΓΣ 2017 ΔΘΚΑ ΥΓΕΙΑ_ENG.pdf

Public permalinkhttp://www.publicnow.com/view/E5D926980BB38E389C8D325833F6B1BE3533FC4E